Awarded
Methylphenidat [Mindestindikation: juvenile ADHS-Therapie]
- Winners
- ALIUD PHARMA GmbH (BG ALIUD / STADAPHARM GbR), Medical Valley Invest AB, MEDICE Arzneimittel Pütter GmbH & Co KG, neuraxpharm Arzneimittel GmbH (BG Zentiva/neuraxpharm GbR), STADAPHARM GmbH (BG ALIUD / STADAPHARM GbR), Zentiva Pharma GmbH (BG Zentiva/neuraxpharm GbR)
- Contract value
- no value published
- Bids received
- 5
- Published
- 19 Sept 2025
- Awarded
- 4 Aug 2025
- Contract start
- 4 Aug 2025